International Journal of Cell Cloning, Vol 10, 2-11, Copyright © 1992 by AlphaMed Press

REVIEWS

Transforming growth factor-beta: a bidirectional regulator of hematopoietic cell growth

JR Keller, SE Jacobsen, CM Dubois, K Hestdal and FW Ruscetti
Biological Carcinogenesis and Development Program, PRI/Dyncorp, Inc., Frederick, Maryland.

It is now apparent that the transforming growth factor-beta (TGF-beta) family of proteins has potent hematopoietic regulatory properties ranging from effects on the growth and differentiation of primitive stem cells to the differentiated functions of mature cells. Although most reports have described the inhibitory activities of TGF-beta on hematopoiesis, recent evidence supports the concept that TGF-beta can have both inhibitory and stimulatory actions on these systems. These differences depend on the differentiation state of the target cell and the other cytokines interacting with the cell. Furthermore, TGF-beta has direct bidirectional effects on cell surface expression of many cytokine receptors suggesting that it is part of the mechanism of action of TGF-beta. The major biological effect of TGF-beta on hematopoietic cell growth is the reversible inhibition of entry into the cell cycle. Importantly, the effect of in vivo administration of TGF-beta has mimicked the in vitro effects. Ultimately, well designed clinical trials will determine whether the exciting potential of TGF- beta can be used to treat or prevent myelotoxicity and other bone marrow dysfunctions.

This article has been cited by other articles:

				R. M. Bohmer IL-3-Dependent Early Erythropoiesis Is Stimulated by Autocrine Transforming Growth Factor Beta Stem Cells, March 1, 2004; 22(2): 216 - 224. [Abstract] [Full Text] [PDF]

				J. Cashman, I. Clark-Lewis, A. Eaves, and C. Eaves Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice Blood, February 1, 2002; 99(3): 792 - 799. [Abstract] [Full Text] [PDF]

				P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation J. Cell Sci., January 2, 2000; 113(3): 383 - 390. [Abstract] [PDF]

				J.D. Cashman, I. Clark-Lewis, A.C. Eaves, and C.J. Eaves Differentiation Stage-Specific Regulation of Primitive Human Hematopoietic Progenitor Cycling by Exogenous and Endogenous Inhibitors in an In Vivo Model Blood, December 1, 1999; 94(11): 3722 - 3729. [Abstract] [Full Text] [PDF]

				A. Peled, J. A. Gonzalo, C. Lloyd, and J.-C. Gutierrez-Ramos The Chemotactic Cytokine Eotaxin Acts as a Granulocyte-Macrophage Colony-Stimulating Factor During Lung Inflammation Blood, March 15, 1998; 91(6): 1909 - 1916. [Abstract] [Full Text] [PDF]

				S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF]

				N Fortunel, P Batard, A Hatzfeld, M. Monier, B Panterne, J Lebkowski, and J Hatzfeld High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells J. Cell Sci., January 7, 1998; 111(13): 1867 - 1875. [Abstract] [PDF]